Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Alternatives for Reducing Harm Using E-cigarettes
Sponsor: Medical University of South Carolina
Summary
For patients in cancer care, quitting smoking is critical, but a significant portion of patients in cancer care refuse all components of tobacco treatment, even when offered free of charge. The proposed clinical trial will assess one harm reduction intervention, switching completely from cigarettes to e-cigarettes, among oncology outpatients who smoke and refuse traditional tobacco treatment. This study is a type 1 hybrid effectiveness-implementation trial among oncology outpatients at an NCI-designated cancer center who smoke and refuse all components of tobacco treatment (N=208).
Official title: A Novel Harm Reduction Approach for Oncology Outpatients Who Smoke and Refuse Traditional Tobacco Treatment
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
208
Start Date
2025-08-25
Completion Date
2029-11-30
Last Updated
2025-12-17
Healthy Volunteers
Yes
Interventions
Harm Reduction (E-cigarette switching)
Participants will be assigned to receive an e-cigarette and try to switch completely from smoking to using the e-cigarette
Standard of Care
Participants will be assigned to receive tobacco treatment referrals and the opportunity to re-enroll in the Tobacco Treatment Program
Locations (1)
Medical University of South Carolina
Charleston, South Carolina, United States